Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3844876 | 0.93 | EPOR (0.33) | MEN1GAAKMT2A | |
| SCHEMBL3841443 | 0.93 | TDP1 (0.39) | MEN1GAAKMT2A | |
| SCHEMBL3498361 | 0.86 | TDP1 (0.33) | — | |
| SCHEMBL7881945 | 0.84 | CPB2 (0.36) | MEN1GAAKMT2A | |
| SCHEMBL14345486 | 0.83 | TDP1 (0.31) | MEN1GAAKMT2A | |
| SCHEMBL5032518 | 0.83 | TDP1 (0.31) | MEN1GAAKMT2A | |
| SCHEMBL4564930 | 0.83 | TDP1 (0.31) | MEN1GAAKMT2A | |
| SCHEMBL8388793 | 0.80 | KDM4E (0.32) | MEN1GAAKMT2A | |
| SCHEMBL12694735 | 0.80 | TDP1 (0.33) | — | |
| SCHEMBL3498662 | 0.80 | MEN1 (0.30) | MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1935435-B1 | Blood pool agents for nuclear magnetic resonance diagnostics | BRACCO IMAGING SPA (IT) | 2017-09-06 | — | — | EP | disclosed |
| EP-1935435-A2 | Blood pool agents for nuclear magnetic resonance diagnostics | Bracco Imaging S.p.A (IT) | 2008-06-25 | — | — | EP | disclosed |
| EP-1259532-B1 | BILE ACIDS CONJUGATES WITH METAL ION CHELATES AND THE USE THEREOF | BRACCO IMAGING SPA (IT) | 2005-05-04 | — | — | EP | disclosed |
| US-6803030-B2 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | BRACCO IMAGING S.P.A. (IT) | 2004-10-12 | — | — | US | disclosed |
| US-20030113265-A1 | Bile acids conjugates with metal ion chelates and the use thereof | BRACCO IMAGING S.P.A. (IT) | 2003-06-19 | — | — | US | disclosed |
| EP-1259532-A1 | BILE ACIDS CONJUGATES WITH METAL ION CHELATES AND THE USE THEREOF | Bracco Imaging S.p.A. (IT) | 2002-11-27 | — | — | EP | disclosed |
| US-6461588-B1 | VASCULAR SYSTEMS | BRACCO IMAGING S.P.A. (IT) | 2002-10-08 | — | — | US | disclosed |
| WO-2001064708-A1 | BILE ACIDS CONJUGATES WITH METAL ION CHELATES AND THE USE THEREOF | BRACCO IMAGING S.P.A. (IT) | 2001-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030113265-A1 | Bile acids conjugates with metal ion chelates and the use thereof | SLC10A2, SLC10A1, NR1H4 | MEN1 168/4885GAA 984/4885KMT2A 3139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.